This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gilles, C. Articles by Foidart, J.-M. Search for Related Content PubMed PubMed Citation Articles by Gilles, C. Articles by Foidart, J.-M.

Transactivation of Vimentin by ß-Catenin in Human Breast Cancer Cells¹

Laboratory of Tumor and Developmental Biology, University of Liège, CHU Sart-Tilman, B23, B-4000 Liège, Belgium [C. G., M. M., P. R., J-M. F.], and Unité INSERM U.514, Laboratoire Pol Bouin, IFR 53, CHU Maison Blanche, Reims, France [M. P., B. N-R., P. B.]

The cytoplasmic and nuclear redistribution of ß-catenin and the de novo expression of vimentin are frequently involved in the epithelial-to-mesenchymal transition associated with increased invasive/migratory properties of epithelial cells. Because ß-catenin can act as a coactivator of transcription through its binding to the T-cell factor (TCF)/lymphoid enhancer factor 1 transcription factor family, we have explored the possibility that ß-catenin/TCF could directly transactivate vimentin. We first compared vimentin expression in relation with the localization of ß-catenin in eight breast cancer cell lines displaying various degrees of invasiveness and in a model of cell migration using human mammary MCF10A cells. We could thus show a cytoplasmic and/or nuclear distribution of ß-catenin in invasive/migratory cells expressing vimentin, but not in noninvasive/stationary vimentin-negative cell lines. In addition, the human vimentin promoter was found to be up-regulated by ß-catenin and TCF-4 cotransfection. Varying with the cellular background, a diminution of this up-regulation was observed when the putative ß-catenin/TCF binding site of the vimentin promoter was mutated. Our results therefore demonstrate that the vimentin promoter is a target of the ß-catenin/TCF pathway and strongly suggest an implication of this regulation in epithelial cell migration/invasion.

This article has been cited by other articles:

				C.-F. Hong, Y.-T. Chou, Y.-S. Lin, and C.-W. Wu MAD2B, a Novel TCF4-binding Protein, Modulates TCF4-mediated Epithelial-Mesenchymal Transdifferentiation J. Biol. Chem., July 17, 2009; 284(29): 19613 - 19622. [Abstract] [Full Text] [PDF]

				P. Alonso-Magdalena, C. Brossner, A. Reiner, G. Cheng, N. Sugiyama, M. Warner, and J.-A. Gustafsson A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia PNAS, February 24, 2009; 106(8): 2859 - 2863. [Abstract] [Full Text] [PDF]

				Y. Oku, T. Shimoji, K. Takifuji, T. Hotta, S. Yokoyama, K. Matsuda, T. Higashiguchi, T. Tominaga, T. Nasu, K. Tamura, et al. Identification of the Molecular Mechanisms for Dedifferentiation at the Invasion Front of Colorectal Cancer by a Gene Expression Analysis Clin. Cancer Res., November 15, 2008; 14(22): 7215 - 7222. [Abstract] [Full Text] [PDF]

				A. Prasad, V. Paruchuri, A. Preet, F. Latif, and R. K. Ganju Slit-2 Induces a Tumor-suppressive Effect by Regulating {beta}-Catenin in Breast Cancer Cells J. Biol. Chem., September 26, 2008; 283(39): 26624 - 26633. [Abstract] [Full Text] [PDF]

				W. Gu, A. L. Wells, F. Pan, and R. H. Singer Feedback Regulation between Zipcode Binding Protein 1 and {beta}-Catenin mRNAs in Breast Cancer Cells Mol. Cell. Biol., August 15, 2008; 28(16): 4963 - 4974. [Abstract] [Full Text] [PDF]

				S. Chu, H. Xu, T. J. Ferro, and P. X. Rivera Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1127 - L1134. [Abstract] [Full Text] [PDF]

				J. R. van Beijnum, R. P. Dings, E. van der Linden, B. M. M. Zwaans, F. C. S. Ramaekers, K. H. Mayo, and A. W. Griffioen Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature Blood, October 1, 2006; 108(7): 2339 - 2348. [Abstract] [Full Text] [PDF]

				Y. Mironchik, P. T. Winnard Jr., F. Vesuna, Y. Kato, F. Wildes, A. P. Pathak, S. Kominsky, D. Artemov, Z. Bhujwalla, P. Van Diest, et al. Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer Cancer Res., December 1, 2005; 65(23): 10801 - 10809. [Abstract] [Full Text] [PDF]

				M. Galie, C. Sorrentino, M. Montani, L. Micossi, E. Di Carlo, T. D'Antuono, L. Calderan, P. Marzola, D. Benati, F. Merigo, et al. Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells Carcinogenesis, November 1, 2005; 26(11): 1868 - 1878. [Abstract] [Full Text] [PDF]

				S. Zhuang, Y. Yan, J. Han, and R. G. Schnellmann p38 Kinase-mediated Transactivation of the Epidermal Growth Factor Receptor Is Required for Dedifferentiation of Renal Epithelial Cells after Oxidant Injury J. Biol. Chem., June 3, 2005; 280(22): 21036 - 21042. [Abstract] [Full Text] [PDF]

				R. E. Bachelder, S.-O. Yoon, C. Franci, A. G. de Herreros, and A. M. Mercurio Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition J. Cell Biol., January 3, 2005; 168(1): 29 - 33. [Abstract] [Full Text] [PDF]

				A. Masszi, L. Fan, L. Rosivall, C. A. McCulloch, O. D. Rotstein, I. Mucsi, and A. Kapus Integrity of Cell-Cell Contacts Is a Critical Regulator of TGF-{beta}1-Induced Epithelial-to-Myofibroblast Transition: Role for {beta}-Catenin Am. J. Pathol., December 1, 2004; 165(6): 1955 - 1967. [Abstract] [Full Text] [PDF]